Tareq Abadl: The Critical Role of ADAMTS13 Activity Testing in Diagnosing TTP
Tareq Abadl, Medical Laboratory Specialist and Director of the Blood Bank at Dr. Abdelkader Al-Mutawakkil Hospital, shared a post on LinkedIn:
“ADAMTS13 Activity Test
What is it?
A laboratory test that measures the activity of the enzyme ADAMTS13, which cleaves ultra-large von Willebrand factor (vWF) multimers into smaller, less thrombogenic fragments.
What does it detect?
Primarily used to diagnose:
- Thrombotic Thrombocytopenic Purpura (TTP)
A rare but life-threatening thrombotic microangiopathy characterized by:
- Severe thrombocytopenia
- Microangiopathic hemolytic anemia
- Neurologic symptoms
- Renal dysfunction
- Fever
Normal Reference Range:
ADAMTS13 activity: ~50–150%
(May vary slightly depending on the laboratory and assay method)
Key Diagnostic Point:
Low ADAMTS13 activity less than 10% – Strongly diagnostic of TTP
The deficiency may be:
- Immune-mediated (autoantibodies against ADAMTS13)
- Congenital (hereditary deficiency)
Why is this test critical?
- TTP is not diagnosed by routine coagulation tests
- Delayed diagnosis can be fatal
- Plasma exchange (PLEX) must be started immediately when TTP is suspected.
Think TTP if you see:
- Decreased Platelets
- Elevated LDH
- Decreased Haptoglobin
- Normal PT / aPTT
Suspect TTP and order ADAMTS13 activity urgently.”
Find more posts featuring Tareq Abadl on Hemostasis Today.
-
Aug 21, 2026, 21:58Toby Richards: WEHI Trial Solidifies IV Iron as Third-Trimester Standard
-
Aug 21, 2026, 21:51Mehak Trehan: From Reading the Chapter to Writing One
-
Aug 21, 2026, 21:38Ann Reilly: Navigating Postoperative vs. Acute Blood Loss Anemia – A CDI Case Study
-
Aug 21, 2026, 21:29Merlin Crossley: Atomic Precision in Sickle Cell Care – Structural Targeting for Fetal Globin Reactivation
-
Aug 21, 2026, 19:09Aphisit Thongthaisin: Admitted to Sorbonne University’s T2H University Diploma for 2026/2027
-
Aug 21, 2026, 19:07José Luis Ferreiro Gutiérrez: Proud to Be Elected Chairperson-Elect of the ESC Working Group on Thrombosis
-
Aug 21, 2026, 19:00Manuel Monreal: New RIETE Registry Data on VTE Recurrence and Bleeding During Anticoagulation
-
Aug 21, 2026, 18:39Ronak H. Mistry: Updated ASH ITP Guidelines Bring New Guidance for Managing ITP
-
Aug 21, 2026, 18:22Ahmed Bennis: NOAC Use Is Associated With Slower Cognitive Decline in AF and Alzheimer’s Disease